Cargando…

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibody (NAb) production is a crucial humoral response that can reduce re-infection or breakthrough infection. The conventional test used to measure NAb production capacity levels is the live virus-neutralizing assay. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Kwok-Hung, Leung, Ka-Yi, Zhang, Ricky-Ruiqi, Liu, Danlei, Fan, Yujing, Chen, Honglin, Yuen, Kwok-Yung, Hung, Ivan Fan-Ngai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534648/ https://www.ncbi.nlm.nih.gov/pubmed/34679455 http://dx.doi.org/10.3390/diagnostics11101757

Ejemplares similares

Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test
por: Chan, Michele Mun Hei, et al.
Publicado: (2022)

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant
por: Zhang, Ruiqi, et al.
Publicado: (2021)

Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
por: Zhang, Ruiqi, et al.
Publicado: (2022)

In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19
por: Lam, Athene Hoi-Ying, et al.
Publicado: (2021)

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
por: Khong, Ka-Wa, et al.
Publicado: (2022)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

High neutralizing antibody titer in intensive care unit patients with COVID-19
por: Liu, Li, et al.
Publicado: (2020)

Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain
por: Ip, Jonathan Daniel, et al.
Publicado: (2021)

Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay
por: Fong, Carol Ho-Yan, et al.
Publicado: (2020)

Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2
por: Chen, Jonathan Hon-Kwan, et al.
Publicado: (2020)

Viral Infections, an Overview with a Focus on Prevention of Transmission
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2017)

Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection
por: Yip, Cyril Chik-Yan, et al.
Publicado: (2020)

Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers
por: Zhou, Ying, et al.
Publicado: (2022)

Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong
por: To, Kelvin Kai-Wang, et al.
Publicado: (2014)

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
por: Chan, Kwok-Hung, et al.
Publicado: (2013)

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
por: Fan, Yu-Jing, et al.
Publicado: (2021)

Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines
por: Zhang, Xiaojuan, et al.
Publicado: (2023)

The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
por: Khong, Ka-Wa, et al.
Publicado: (2022)

Neurosensory Rehabilitation and Olfactory Network Recovery in Covid-19-related Olfactory Dysfunction
por: Chung, Tom Wai-Hin, et al.
Publicado: (2021)

Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management
por: To, Kelvin Kai-Wang, et al.
Publicado: (2010)

Evolution and Control of COVID-19 Epidemic in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

CS-2034 mRNA vaccine: a new option for COVID-19 infection?
por: Zhang, Ruiqi, et al.
Publicado: (2023)

Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19)
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2020)

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
por: Kim, Sun Jin, et al.
Publicado: (2022)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus
por: Chen, Yixin, et al.
Publicado: (2015)

Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine
por: Chen, Lin-Lei, et al.
Publicado: (2022)

Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes
por: Wong, Chun-Ka, et al.
Publicado: (2022)

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
por: Lu, Lu, et al.
Publicado: (2022)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
por: Springer, David Niklas, et al.
Publicado: (2023)

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
por: Lu, Lu, et al.
Publicado: (2021)

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
por: Chen, Honglin, et al.
Publicado: (2009)

Unexpectedly Higher Morbidity and Mortality of Hospitalized Elderly Patients Associated with Rhinovirus Compared with Influenza Virus Respiratory Tract Infection
por: Hung, Ivan F. N., et al.
Publicado: (2017)

A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies
por: Pi-Estopiñan, Franciscary, et al.
Publicado: (2022)

Introduction of an electronic monitoring system for monitoring compliance with Moments 1 and 4 of the WHO "My 5 Moments for Hand Hygiene" methodology
por: Cheng, Vincent CC, et al.
Publicado: (2011)

Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level
por: Wang, Xiaoli, et al.
Publicado: (2018)

Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
por: Sholukh, Anton M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9ghcpi7p1bop1hj469fu88dtb